New Fully Automated Preparation of High Apparent Molar Activity <sup>68</sup>Ga-FAPI-46 on a Trasis AiO Platform

A large number of applications for fibroblast activation protein inhibitors (FAPI)-based PET agents have been evaluated in conditions ranging from cancer to non-malignant diseases such as myocardial infarction. In particular, <sup>68</sup>Ga-FAPI-46 was reported to have a high specificit...

Full description

Bibliographic Details
Published in:Molecules
Main Authors: Chiara Da Pieve, Marta Costa Braga, David R. Turton, Frank A. Valla, Pinar Cakmak, Karl-Heinz Plate, Gabriela Kramer-Marek
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Subjects:
FAP
gallium-68
FAPI-46
automated radiosynthesis
Trasis AiO
preclinical PET
Online Access:https://www.mdpi.com/1420-3049/27/3/675

Internet

https://www.mdpi.com/1420-3049/27/3/675

Similar Items